ACT GENOMICS CO., LTD.
Area: Precision Medicine
Booth No: M228
ACT Genomics is a world-leading cancer solution provider. Based in Taiwan with offices in Singapore, Hong Kong, and Japan, we are dedicated to providing cancer patients personalized genomic information based-treatment plans, cancer relapse and drug-resistant monitoring, risk assessment, and immunotherapy evaluation through our cutting-edge Next Generation Sequencing (NGS) platform. Our comprehensive portfolio received Asia Pacific Molecular Diagnostics Product Strategy Award by Frost & Sullivan.
Exhibitors you may be interested in